Learning Objectives:
- Understand the significance of PTEN-deficiency in advanced malignancies
- Learn the impact of PTEN-deficiency on the tumor microenvironment
- Understand potential means by which PTEN-deficient malignancies evade the immune system, and consider potential interventions to manipulate those mechanisms.
and
- Review the spectrum of immune-related adverse events (irAEs)
- Describe the hematologic toxicities associated with immune checkpoint inhibitors (ICI) and the recommended management
- Discuss the potential role of ICIs in hematologic malignancies
Session date:
10/29/2018 - 12:00pm to 1:00pm CDT
Location:
UCMC
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Meghan R. Steiner, MD and Amy Wang, MD, MPH